Amgen defends anemia drugs before U.S. panel
543431
Drugs that treat anemia caused by kidney failure provide important benefits despite the risks for some patients at high doses, Amgen Inc. told a U.S. advisory panel on Tuesday.
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
580228
A group of people with Parkinson's disease that had taken a drug as part of a trial pleaded with Amgen to allow them to resume taking it, but the company said no.
114399
Pfizer Inc., the world&#39;s biggest drugmaker, defended its painkiller Celebrex after a researcher&#39;s suggestion the medication may be linked to heart risks sent the stock down as much as 8.3 percent.
564679
Documents released ahead of an FDA meeting foretell a tougher future for Amgen's top drugs.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
186518
A proposed leukemia drug should not receive federal approval, government advisers recommended Wednesday.
479663
Lawmakers push to ease restrictions on anemia compounds from Amgen and Johnson & Johnson.
231400
WASHINGTON -- Biotechnology lobbyists attempting to slow the development of cheap generic versions of the world's most expensive drugs have been emphasizing questions about their safety in an effort to win support among the new Democratic leaders of Congress.
457732
The Food and Drug Administration said Thursday that accumulating evidence suggests a Bayer AG drug used to prevent excessive bleeding during heart bypass surgery increases the risk of death when compared with other drugs.
189562
The Food and Drug Administration warned yesterday that anemia-fighting drugs called erythropoietins, which had $10 billion in U.S. sales last year, are being used so aggressively that they may be harming some patients.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
256991
Medicare payment policies for Amgen Inc.'s antianemia drug Epogen were criticized yesterday during a congressional hearing as "perverse" and potentially dangerous to kidney dialysis patients.
227534
AMDL, Inc (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, today announced that a new study by six researchers in the Medical Department, University ...
726765
Amgen Inc. has added a warning to  its anemia drug, Aranesp, for kidney dialysis and cancer  patients after studies on similar drugs showed higher doses can  cause blood clots and death, the company said a letter released  on Friday.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.